Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use PANRETIN GEL safely and effectively. See full prescribing information for PANRETIN GEL. PANRETIN GEL (alitretinoin) 0.1%, for topical use Initial U.S. Approval: 1999
Medication labelWhy this: Advisory · dailymed-prescription
1.1 Kaposi’s Sarcoma PANRETIN GEL is indicated for topical treatment of cutaneous lesions in adults with AIDS related Kaposi’s sarcoma (KS). Limitations of Use: PANRETIN GEL is not indicated when systemic anti-KS therapy is required (including more than 10 new KS lesions in the prior month, symptomatic lymphedema, symptomatic pulmonary KS, or symptomatic visceral involvement) [see Clinical Studies (14.1)].
- generic_name
- alitretinoin
- product_names
- alitretinoin
- ndc
- 59212-601, 59212-601-22
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en